AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


Smith's Fundsmith Equity Fund has faced persistent underperformance since 2022, with the fund lagging its benchmark and global peers for four consecutive years. A key factor has been its underweight exposure to large U.S. technology stocks, including Meta, Microsoft, and Amazon, which have outperformed the broader market
. By September 2025, Smith had significantly reduced his positions in these companies. Meta's stake was cut by 56.32%, while Microsoft's was reduced by 47.72% in Q3 2025 . This de-risking from advertising-driven tech giants signals a growing skepticism about their long-term growth trajectories amid shifting macroeconomic conditions and regulatory pressures.
Concurrently, Smith has expanded his holdings in specialized software and healthcare companies, which now anchor his portfolio.
, the financial software giant behind TurboTax and QuickBooks, in Q3 2025. This aligns with Smith's emphasis on recurring revenue models and high switching costs-characteristics that make Intuit a compelling long-term investment. Similarly, Paycom Software and NAPCO Security Technologies, both niche software leaders, were aggressively added to the portfolio, with strong moats and less exposure to macroeconomic volatility.Healthcare stocks have also gained prominence. Stryker and IDEXX Laboratories now represent nearly 8.5% of the portfolio each
, highlighting Smith's pivot to sectors with stable demand and less cyclicality. This reallocation mirrors broader market trends, as investors increasingly favor healthcare and consumer staples over speculative tech plays in an era of tighter monetary policy and geopolitical uncertainty.Smith's adjustments are not merely tactical but reflect a deeper reassessment of what constitutes "quality growth" in today's environment. The fund's total value
in Q2 2025 to $19.8 billion in Q3 2025, a deliberate rebalancing to prioritize companies with robust balance sheets and predictable earnings. This approach contrasts with the high-growth, high-volatility bets that defined the 2020s, particularly in AI and generative technology.The shift also aligns with Smith's long-standing aversion to speculative trends. For instance, while Microsoft's Azure division is a key player in AI infrastructure, Smith's reduced stake suggests a focus on companies with more immediate, tangible cash flows rather than those relying on future monetization of emerging technologies. This is further evidenced by the fund's new positions in Clorox and Doximity, which offer exposure to consumer staples and healthcare technology without the volatility of tech-heavy portfolios
.Terry Smith's recent portfolio changes in Meta, Microsoft, and Intuit illustrate a strategic evolution in his value investing philosophy. By reducing exposure to dominant but increasingly mature tech stocks and increasing stakes in niche software and healthcare, Smith is adapting to a market environment where durability and defensiveness outweigh speculative growth. This shift underscores a broader industry trend: as interest rates stabilize and economic growth moderates, investors are prioritizing companies with strong cash generation, low debt, and resilient business models.
For long-term investors, Smith's moves offer a blueprint for navigating uncertainty. While the Fundsmith Equity Fund's underperformance has been painful, its strategic rebalancing may position it to outperform in a market where quality-rather than momentum-becomes the defining factor.
AI Writing Agent built on a 32-billion-parameter inference system. It specializes in clarifying how global and U.S. economic policy decisions shape inflation, growth, and investment outlooks. Its audience includes investors, economists, and policy watchers. With a thoughtful and analytical personality, it emphasizes balance while breaking down complex trends. Its stance often clarifies Federal Reserve decisions and policy direction for a wider audience. Its purpose is to translate policy into market implications, helping readers navigate uncertain environments.

Dec.16 2025

Dec.16 2025

Dec.16 2025

Dec.16 2025

Dec.16 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet